Clinical

FHI Clinical Providing Full-Service CRO Capabilities for Coronavirus (COVID-19) Clinical Trial

Friday, April 3, 2020 - 2:00pm

FHI Clinical Inc. announces today it has partnered with Infectious Disease Research Institute (IDRI) , a Seattle-based not-for-profit organization, to provide full-service contract research organization (CRO) capabilities for an immunotherapy clinical trial to combat moderate to severe cases of COVID-19.

Key Points: 
  • FHI Clinical Inc. announces today it has partnered with Infectious Disease Research Institute (IDRI) , a Seattle-based not-for-profit organization, to provide full-service contract research organization (CRO) capabilities for an immunotherapy clinical trial to combat moderate to severe cases of COVID-19.
  • Casper is hopeful this immunotherapy can be introduced to the market within a year, pending clinical trial success.
  • When an outbreak like coronavirus occurs, new therapies and vaccines are vital and require rapid start-up of clinical trials, commented Ted FitzGerald, FHI Clinical president and CEO.
  • FHI Clinical is a full-service contract research organization (CRO) with the global expertise, responsive approaches and proven solutions to manage complex clinical research in resource-limited settings around the world.

Clinical Trial Media Introduces New Website, Covid19ClinicalTrial.com

Tuesday, March 31, 2020 - 1:38pm

HAUPPAUGE, N.Y., March 31, 2020 /PRNewswire/ --Clinical Trial Media, a data-driven, global patient recruitment and retention company offering a wide variety of services for clinical trials, announced the debut of a new website, Covid19ClinicalTrial.com .

Key Points: 
  • HAUPPAUGE, N.Y., March 31, 2020 /PRNewswire/ --Clinical Trial Media, a data-driven, global patient recruitment and retention company offering a wide variety of services for clinical trials, announced the debut of a new website, Covid19ClinicalTrial.com .
  • "With so much misinformation going around about COVID-19, I felt it necessary to create a centralized, trusted resource for all information related to Coronavirus clinical research," said Cara Brant, CEO of Clinical Trial Media.
  • "Having a single source for trustworthy information is so important to people who are already confused and scared enough about COVID-19 and need reassurance and facts they can trust," said Andrew Pollack, VP of Marketing for Clinical Trial Media.
  • For more information about the work being done by Clinical Trial Media, visit www.clinicaltrialmedia.com .

Clinical Trial Report Week 20th-24th January 2020: Seventeen Companies Reported Headline Results in Advancing their Candidate Product through Clinical Trials - ResearchAndMarkets.com

Monday, March 9, 2020 - 2:15pm

The "Clinical Trial Report Week 20th - 24th January 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Clinical Trial Report Week 20th - 24th January 2020" report has been added to ResearchAndMarkets.com's offering.
  • This is a summarised report of new drug therapies in clinical trials worldwide during the week of the 20th - 24th January 2020.
  • The purpose of this report is to present accurate and timely information on clinical trials worldwide, in the anticipation that resources for future clinical trials may be better allocated and development costs lowered.
  • All content given in this report is for informational purposes only and does not constitute patient, clinical or financial advice.

Global Clinical Trial Supplies Market Insights, 2020-2025 by Products & Services, Phases, Drug Types, Therapeutic Areas and Regions - ResearchAndMarkets.com

Friday, March 6, 2020 - 10:33am

Based on service, the clinical trial supplies market is segmented into logistics; distribution, storage, and retention; packaging, labeling, and blinding; manufacturing; comparator sourcing; and solutions.

Key Points: 
  • Based on service, the clinical trial supplies market is segmented into logistics; distribution, storage, and retention; packaging, labeling, and blinding; manufacturing; comparator sourcing; and solutions.
  • The logistics services segment is expected to account for the largest share of the clinical trial supplies market during the forecast period.
  • Oncology segment to account for the largest share of the clinical trial supplies market, by therapeutic area, in 2020
    Based on the therapeutic area, the clinical trial supplies market is segmented into oncology, neurological and mental disorders, infectious and immune system diseases, digestive system diseases, blood disorders, and other therapeutic areas.
  • In 2020, North America is estimated to be the largest regional market for clinical trial supplies, followed by Europe.

NantHealth to Report 2019 Fourth-Quarter Financial Results and Host Conference Call on Friday, February 28

Monday, February 24, 2020 - 11:54am

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2019 fourth quarter on Friday, February 28, 2020, after market close.

Key Points: 
  • NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2019 fourth quarter on Friday, February 28, 2020, after market close.
  • NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m.
  • The conference call will be available to interested parties by dialing 844-309-3709 from the U.S. or Canada, or 281-962-4864 from international locations, passcode 9998343.
  • NantHealth enables the use of cutting-edge data and technology toward the goals of empowering clinical decision support and improving patient outcomes.

ConvergeHEALTH by Deloitte Launches Patient-Centered Digital Health Platform to Support Global Clinical Trials at SCOPE Summit 2020

Tuesday, February 18, 2020 - 1:30pm

ORLANDO, Fla., Feb. 18, 2020 /PRNewswire/ -- ConvergeHEALTH by Deloitte today announced the launch of MyPATH for Clinical, a cloud-based digital platform designed to enhance the patient experience as well as the success and efficiency of global clinical trials.

Key Points: 
  • ORLANDO, Fla., Feb. 18, 2020 /PRNewswire/ -- ConvergeHEALTH by Deloitte today announced the launch of MyPATH for Clinical, a cloud-based digital platform designed to enhance the patient experience as well as the success and efficiency of global clinical trials.
  • MyPATH for Clinical is a modular, patient-centric platform that can help accelerate the execution of digital clinical trials by taking a holistic approach to connect clinical trial participants, investigators and clinical research associates.
  • Personalized digital patient engagement with guidance and support along the clinical trial lifecycle with enhanced direct connectivity to investigators and patient communities.
  • For more information, stop by Deloitte booth #817 at the SCOPE Summit in Orlando, Feb. 18-21, 2010, or visit the ConvergeHEALTH website .

SimpleTrials CTMS to be Showcased at SCOPE 2020

Friday, February 14, 2020 - 1:00pm

OAKLAND, Calif., Feb. 14, 2020 /PRNewswire-PRWeb/ -- Trial By Fire Solutions, a leader in web-based clinical trial management solutions (CTMS) that include integrated eTMF and Payment tracking, will be showcasing SimpleTrials at the Summit For Clinical Ops Executives (SCOPE) on February 19-20, 2020, in Orlando, FL.

Key Points: 
  • OAKLAND, Calif., Feb. 14, 2020 /PRNewswire-PRWeb/ -- Trial By Fire Solutions, a leader in web-based clinical trial management solutions (CTMS) that include integrated eTMF and Payment tracking, will be showcasing SimpleTrials at the Summit For Clinical Ops Executives (SCOPE) on February 19-20, 2020, in Orlando, FL.
  • Customers can now extend the core CTMS and eTMF features with more customized tracking options.
  • "We are delighted to be returning to the SCOPE Summit to show how clinical teams of all sizes have a complete, affordable option with SimpleTrials CTMS and eTMF."
  • Developed by clinical trial professionals with over 20 years of experience, SimpleTrials is designed for sponsors, sites and vendors.

POC Clinical Chemistry & Immunodiagnostics Market, 2020: Physician Offices, ERs, ORs, ICU/CCUs, Cancer Clinics, Nursing Homes, Ambulatory Care, Surgery & Birth Centers - ResearchAndMarkets.com

Thursday, February 6, 2020 - 10:47am

The "2020 POC Clinical Chemistry and Immunodiagnostics Market: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts - Physician Offices, ERs, ORs, ICU/CCUs, Cancer Clinics, Nursing Homes, Ambulatory Care, Surgery and Birth Centers" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "2020 POC Clinical Chemistry and Immunodiagnostics Market: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts - Physician Offices, ERs, ORs, ICU/CCUs, Cancer Clinics, Nursing Homes, Ambulatory Care, Surgery and Birth Centers" report has been added to ResearchAndMarkets.com's offering.
  • This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC clinical chemistry market.
  • Review of leading clinical chemistry analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.
  • Specific opportunities for new clinical chemistry instruments and reagent systems with potentially significant market appeal during the next five years.

2020 Clinical Chemistry & Immunodiagnostic Analyzers & Reagents for 100 Tests - US, Japan, Germany, France, Spain, Italy & the UK - ResearchAndMarkets.com

Wednesday, February 5, 2020 - 11:45am

The "2020 Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Tests: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts by Test, Emerging technologies, Latest Instrumentation" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "2020 Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Tests: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts by Test, Emerging technologies, Latest Instrumentation" report has been added to ResearchAndMarkets.com's offering.
  • The author's new report is a seven-country strategic analysis of major business opportunities emerging in the global clinical chemistry and immunodiagnostic markets during the next five years.
  • The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.
  • Analysis of current and emerging clinical chemistry and immunodiagnostic tests.

Global Clinical Trial Packaging Market Expected to Grow with a CAGR of Over 4% During the Forecast Period, 2020-2024 - ResearchAndMarkets.com

Tuesday, January 21, 2020 - 4:46pm

The author has been monitoring the global clinical trial packaging market, and it is poised to grow by USD667.92 million during 2020-2024, progressing at a CAGR of over 4% during the forecast period.

Key Points: 
  • The author has been monitoring the global clinical trial packaging market, and it is poised to grow by USD667.92 million during 2020-2024, progressing at a CAGR of over 4% during the forecast period.
  • Our reports on global clinical trial packaging market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
  • Also, the advent of AI in clinical research is anticipated to boost the growth of the global clinical trial packaging market as well.
  • This study identifies advent of AI in clinical research as the prime reason driving the global clinical trial packaging market growth during the next few years.